Risk Factors Associated with Severity and Death from COVID-19 in Iran: A Systematic Review and Meta-Analysis Study

Abstract

Objectives: This study aims to investigate the risk factors associated with severity and death from COVID-19 through a systematic review and meta-analysis of the published documents in Iran. Methods: A systematic search was performed based on all articles indexed in Scopus, Embase, Web of Science (WOS), PubMed, and Google Scholar in English and Scientific Information Database (SID) and Iranian Research Institute for Information Science and Technology (IRA)NDOC indexes in Persian. To assess quality, we used the Newcastle Ottawa Scale. Publication bias was assessed using Egger's tests. Forest plots were used for a graphical description of the results. We used HRs, and ORs reported for the association between risk factors and COVID-19 severity and death. Results: Sixty-nine studies were included in the meta-analysis, of which 62 and 13 had assessed risk factors for death and severity, respectively. The results showed a significant association between death from COVID-19 and age, male gender, diabetes, hypertension, cardiovascular disease (CVD), cerebrovascular disease, chronic kidney disease (CKD), Headache, and Dyspnea. We observed a significant association between increased white blood cell (WBC), decreased Lymphocyte, increased blood urea nitrogen (BUN), increased creatinine, vitamin D deficiency, and death from COVID-19. There was only a significant relationship between CVD and disease severity. Conclusion: It is recommended that the predictive risk factors of COVID-19 severity and death mentioned in this study to be used for therapeutic and health interventions, to update clinical guidelines and determine patients’ prognoses.

Factors Associated with All-Cause 30-Day Mortality in Indonesian Inpatient COVID-19 Patients at Cipto Mangunkusumo National General Hospital

“…This study was the first to investigate the factors associated with 30-day mortality in COVID-19 patients in Indonesia. This study found that the severity of the COVID-19 infection is a major risk factor for 30-day mortality, similar to other studies [20][21][22]. Also, this finding is similar to other infections, such as pneumonia, sepsis, and meningitis, where the more severe the infection is, the higher the likelihood for complications and mortality.…”

The Role of Sequentially Monitored Laboratory Values and Inflammatory Biomarkers in Assessing the Severity of COVID-19

“…The findings of this study provide supporting evidence in line with existing guidelines, suggesting that the presence of dyspnea and low SPO2 levels at admission, as well as the presence of extensive pneumonia observed on thorax CT scans, are associated with severe disease in patients diagnosed with COVID-19 pneumonia [2,10]. In a meta-analysis that included the evaluation of 69 studies [11], a significant association was found between the symptoms of dyspnea and mortality. Similarly, in our study, we observed a significant increase in dyspnea as a presenting symptom among patients with severe disease (p=0.005).…”

“…Similarly, in our study, we observed a significant increase in dyspnea as a presenting symptom among patients with severe disease (p=0.005). While advanced age, male gender, and the presence of hypertension, diabetes, and cardiovascular comorbidities are known risk factors for severe disease and mortality in COVID-19 [10][11][12][13]. Incompatible with the literature, no significant differences were observed between the two groups in terms of gender, age, and comorbidities in this study.…”

Impacts of the COVID-19 pandemic on pediatric and adult patients with hemophilia

“…However, the infection of SARS-CoV-2 has resulted in millions of deaths worldwide and seriously threatened human health in the last 3 years. Studies have shown that COVID-19-related death is signi cantly associated with chronic diseases like diabetes, hypertension, cardiovascular disease, cerebrovascular disease, and chronic kidney disease [3].…”